Exeltis develops and sells prescription drug products for dermatological conditions, such as scars, fungal infections, and skin disorders. Their product lineup includes recedo topical gel for scar treatment, ecoza for fungal infections, neosalus for dermatitis, atrapro for burning and itching, salvax for hyperkeratotic skin disorders, and hydro 35 foam for skin softening. In 2013, Exeltis was acquired by Everett Labs. Founded in 2003, the company is based in Newtown, Pennsylvania.